R Emkey
Overview
Explore the profile of R Emkey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reginster J, Adami S, Lakatos P, Greenwald M, Stepan J, Silverman S, et al.
Ann Rheum Dis
. 2005 Dec;
65(5):654-61.
PMID: 16339289
Background: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. Objective: To...
2.
Johnson M, Nisenbaum E, Large T, Emkey R, Baez M, Kingston A
Biochem Soc Trans
. 2004 Oct;
32(Pt 5):881-7.
PMID: 15494040
Although relatively few G-protein-coupled receptors are Class C, in recent years, this small family of receptors has become a focal point for the discovery of new and exciting allosteric modulators....
3.
Delmas P, Recker R, Chesnut 3rd C, Skag A, Stakkestad J, Emkey R, et al.
Osteoporos Int
. 2004 Apr;
15(10):792-8.
PMID: 15071723
Increasing evidence suggests that a high rate of bone turnover is associated with low bone mineral density (BMD) and is strongly linked to fracture risk. Measurement of biochemical markers of...
4.
Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, et al.
Diabetologia
. 2002 Jul;
45(5):657-67.
PMID: 12107746
Aims/hypothesis: We examined the properties of a mutant insulin receptor (IR) with an Arg(252) to Cys (IR(R252C)) substitution in the alpha-subunit originally identified in a patient with extreme insulin resistance...
5.
Tsuruzoe K, Emkey R, Kriauciunas K, Ueki K, Kahn C
Mol Cell Biol
. 2000 Dec;
21(1):26-38.
PMID: 11113178
To investigate the roles of insulin receptor substrate 3 (IRS-3) and IRS-4 in the insulin-like growth factor 1 (IGF-1) signaling cascade, we introduced these proteins into 3T3 embryonic fibroblast cell...
6.
Tonino R, Meunier P, Emkey R, Menkes C, Wasnich R, Bone H, et al.
J Clin Endocrinol Metab
. 2000 Sep;
85(9):3109-15.
PMID: 10999794
We report here the second 2-yr extension of a clinical trial among postmenopausal women; 235 women continued blinded treatment with 5 or 10 mg alendronate daily, and 115 women who...
7.
Schnitzer T, Bone H, Crepaldi G, Adami S, McClung M, Kiel D, et al.
Aging (Milano)
. 2000 Apr;
12(1):1-12.
PMID: 10746426
Dosing convenience is a key element in the effective management of any chronic disease, and is particularly important in the long-term management of osteoporosis. Less frequent dosing with any medication...
8.
Bone H, Greenspan S, McKeever C, Bell N, Davidson M, Downs R, et al.
J Clin Endocrinol Metab
. 2000 Feb;
85(2):720-6.
PMID: 10690882
The bisphosphonate alendronate and conjugated equine estrogens are both widely used for the treatment of postmenopausal osteoporosis. Acting by different mechanisms, these two agents decrease bone resorption and thereby increase...
9.
Saag K, Emkey R, Schnitzer T, Brown J, Hawkins F, Goemaere S, et al.
N Engl J Med
. 1998 Jul;
339(5):292-9.
PMID: 9682041
Background: Osteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment. Methods: We carried out two 48-week, randomized, placebo-controlled studies of...
10.
Inoue G, Cheatham B, Emkey R, Kahn C
J Biol Chem
. 1998 Jun;
273(19):11548-55.
PMID: 9565570
The ability of the insulin receptor to phosphorylate multiple substrates and their subcellular localization are two of the determinants that contribute to diversity of signaling. We find that insulin receptor...